The median survival time for the entire sample was 34 months.

二年及五年的存活率各为65%及25%.

互联网

Median survival in the patients with SCLC was 3 months, with NSCLC was 8 . 5 months.

SCLC和NSCLC的中位生存期分别为3个月和8.5个月.

互联网

The median survival period of chemotherapy and chemotherapy plus monoclonal antibody therapy were both 18.0 months.

单克隆抗体治疗组及全身化疗为主但无单克隆抗体治疗组的中位生存期均为18.0个月,尚未发现两组之间生存期上的差别.

互联网